Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 9/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL29576707 | 1.00 | GPR3 (0.50) | GPR3ACHEALOX12LMNATSHR | |
| Trifluoromethanesulfonic Acid SCHEMBL28640172 | 0.96 | GPR3 (0.50) | GPR3ACHEALOX12LMNATSHR | |
| Trifluoromethanesulfonic Acid SCHEMBL28131824 | 0.96 | GPR3 (0.50) | GPR3ACHEALOX12LMNATSHR | |
| Trifluoromethanesulfonic Acid SCHEMBL19915287 | 0.96 | GPR3 (0.50) | GPR3ACHEALOX12LMNATSHR | |
| Trifluoromethanesulfonic Acid SCHEMBL1088679 | 0.81 | GPR3 (0.47) | GPR3ACHEALOX12KCNH2CA9 | |
| Trifluoromethanesulfonic Acid SCHEMBL2851342 | 0.81 | GPR3 (0.47) | GPR3ACHEALOX12KCNH2CA9 | |
| Trifluoromethanesulfonic Acid SCHEMBL36147 | 0.81 | GPR3 (0.47) | GPR3ACHEALOX12KCNH2CA9 | |
| Trifluoromethanesulfonic Acid SCHEMBL29642024 | 0.81 | GPR3 (0.48) | GPR3ACHEKCNH2CA9CA1 | |
| Trifluoromethanesulfonic Acid SCHEMBL160986 | 0.81 | GPR3 (0.48) | GPR3ACHEKCNH2CA9CA1 | |
| Trifluoromethanesulfonic Acid SCHEMBL180454 | 0.80 | TSHR (0.50) | GPR3ACHEALOX12LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 285 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024097736-A1 | PROCESSES FOR PREPARING AZOLOPYRIMIDINE COMPOUNDS | ARCUS BIOSCIENCES, INC. (US) | 2024-05-10 | — | — | WO | claimed |
| US-20230399343-A1 | PROCESS OF MAKING CFTR MODULATORS | VERTEX PHARMACEUTICALS (SAN DIEGO) LLC | 2023-12-14 | — | — | US | claimed |
| CN-117209457-A | Synthesis of alpha-chiral amidine compound | 四川师范大学 | 2023-12-12 | — | — | CN | claimed |
| WO-2023229323-A1 | METHOD FOR PREPARING 6-METHOXYPYRIDIN-3-YL DERIVATIVE | 일동제약(주) | 2023-11-30 | — | — | WO | claimed |
| EP-4126862-A1 | PROCESS FOR PREPARING A COT INHIBITOR COMPOUND | GILEAD SCIENCES, INC. (US) | 2023-02-08 | — | — | EP | claimed |
| US-20220389310-A1 | LUMINESCENT MATERIALS AND METHODS THEREOF | UNIVERSITY OF WASHINGTON (US) | 2022-12-08 | — | — | US | claimed |
| CN-115397824-A | Process for preparing COT inhibitor compounds | 吉利德科学公司 | 2022-11-25 | — | — | CN | claimed |
| WO-2021202688-A1 | PROCESS FOR PREPARING A COT INHIBITOR COMPOUND | GILEAD SCIENCES, INC. (US) | 2021-10-07 | — | — | WO | claimed |
| WO-2021062035-A1 | LUMINESCENT MATERIALS AND METHODS THEREOF | UNIVERSITY OF WASHINGTON (US) | 2021-04-01 | — | — | WO | claimed |
| EP-2460789-B1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2017-04-19 | — | — | EP | claimed |
| US-9346686-B2 | Copper-containing nanocrystals and methods of preparation therefor | THE UNIVERSITY OF WESTERN ONTARIO (CA) | 2016-05-24 | — | — | US | claimed |
| US-20150360967-A1 | COPPER-CONTAINING NANOCRYSTALS AND METHODS OF PREPARATION THEREFOR | THE UNIVERSITY OF WESTERN ONTARIO (CA) | 2015-12-17 | — | — | US | claimed |
| US-9079830-B2 | Method for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-07-14 | — | — | US | claimed |
| EP-2460789-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2012-06-06 | — | — | EP | claimed |
| US-20120123154-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-17 | — | — | US | claimed |
| US-20090105257-A1 | AMINOPHENYLCYCLOPROPYL CARBOXYLIC ACIDS AND DERIVATIVES AS AGONISTS TO GPR40 | GLAXOSMITHKLINE LLC | 2009-04-23 | — | — | US | claimed |
| WO-2005051890-A1 | AMINOPHENYLCYCLOPROPYL CARBOXYLIC ACIDS AND DERIVATIVES AS AGONISTS TO GPR40 | SMITHKLINE BEECHAM CORPORATION (US) | 2005-06-09 | — | — | WO | claimed |
| US-20240199579-A1 | PROCESS FOR PREPARING A COT INHIBITOR COMPOUND | GILEAD SCIENCES, INC. | 2024-06-20 | — | — | US | disclosed |
| US-20040022986-A1 | Limited-play optical media with improved shelf-life and playability | GENERAL ELECTRIC COMPANY | 2004-02-05 | — | — | US | disclosed |
| WO-2004010426-A2 | LIMITED-PLAY OPTICAL MEDIA WITH IMPROVED SHELF-LIFE AND PLAYABILITY | GENERAL ELETRIC COMPANY (US) | 2004-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399343-A1 | PROCESS OF MAKING CFTR MODULATORS | CFTR, SLC26A4, TMEM109 | GPR3 1023/4885ACHE 4027/4885ALOX12 2899/4885 |
| US-20240199579-A1 | PROCESS FOR PREPARING A COT INHIBITOR COMPOUND | TPO, TFPI, TFPI2 | GPR3 4884/4885ACHE 2120/4885ALOX12 2573/4885 |
| US-20090105257-A1 | AMINOPHENYLCYCLOPROPYL CARBOXYLIC ACIDS AND DERIVATIVES AS AGONISTS TO GPR40 | GPR65, GPR88, GPR84 | GPR3 15/4885ACHE 4739/4885ALOX12 971/4885 |
| US-20120123154-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | AKR7A2, AOC2, CBR1 | GPR3 2107/4885ACHE 2583/4885ALOX12 1046/4885 |
| US-20220389310-A1 | LUMINESCENT MATERIALS AND METHODS THEREOF | TYR, GSTA2, CYBA | GPR3 2806/4885ACHE 542/4885ALOX12 1114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.